SHORT-TERM COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR VERSUS INSULIN NEUTRAL PROTAMINE HAGEDORN (NPH) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN SPAIN

被引：0
|
作者：
Ramirez de Arellano, A. [1 ]
Morales, C. [2 ]
De Luis, D. [3 ]
Ferrario, M. G. [4 ]
Lizan, L. [4 ]
机构：
[1] Novo Nordisk Pharma SA, Madrid, Spain
[2] Hosp Virgen de la Macarena, Seville, Spain
[3] Hosp Rio Hortega, Valladolid, Spain
[4] Outcomes10, Castellon de La Plana, Spain
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB63
引用
收藏
页码：A343 / A343
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Morales, Cristobal
    de Luis, Daniel
    Ramirez de Arellano, Antonio
    Giovanna Ferrario, Maria
    Lizan, Luis
    [J]. DIABETES THERAPY, 2015, 6 (04) : 593 - 610
  • [2] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Cristóbal Morales
    Daniel de Luis
    Antonio Ramírez de Arellano
    Maria Giovanna Ferrario
    Luis Lizán
    [J]. Diabetes Therapy, 2015, 6 : 593 - 610
  • [3] Cost-effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Portugal
    Cardoso, Cristina
    Ramirez de Arellano, Antonio
    Prades, Miriam
    Lizan, Luis
    [J]. JOURNAL OF DIABETES & METABOLISM, 2016, 7 (03)
  • [4] Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
    Pollock, Richard F.
    Chubb, Barrie
    Valentine, William J.
    Heller, Simon
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2018, 11 : 217 - 226
  • [5] SHORT-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR VERSUS NPH INSULIN IN INSULIN-NAIVE SUBJECTS WITH TYPE 2 DIABETES IN SWEDEN
    Ridderstrale, M.
    Ericsson, A.
    Jensen, M. M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A480 - A480
  • [6] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Unchalee Permsuwan
    Nathorn Chaiyakunapruk
    Piyameth Dilokthornsakul
    Kednapa Thavorn
    Surasak Saokaew
    [J]. Applied Health Economics and Health Policy, 2016, 14 : 281 - 292
  • [7] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Permsuwan, Unchalee
    Chaiyakunapruk, Nathorn
    Dilokthornsakul, Piyameth
    Thavorn, Kednapa
    Saokaew, Surasak
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2016, 14 (03) : 281 - 292
  • [8] COST-EFFECTIVENESS OF TRANSFERRING TYPE 2 DIABETIC PATIENTS FROM NEUTRAL PROTAMINE HAGEDORN (NPH) TO DETEMIR IN PORTUGAL SETTINGS
    Carvalho, D.
    Lindner, L.
    Kozarzewski, M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A479 - A480
  • [9] COMPARISON OF HYPOGLYCEMIA BETWEEN COMBINATION OF INSULIN DETEMIR AND ASPART WITH COMBINATION OF NPH (NEUTRAL PROTAMINE HAGEDORN) AND REGULAR INSULIN IN PATIENTS OF TYPE 1 DIABETES MELLITUS
    Hussain, Ibrar
    Ul Javed, Soud
    Abid, Ali Farhan
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (04): : 7488 - 7499
  • [10] Detemir versus Insulin Neutral Protamine Hagedorn for Diabetes Mellitus: A Comparative-Effectiveness, Randomized Controlled Trial
    Bartal, Michal Fishel
    Ward, Clara
    Blackwell, Sean C.
    Cornthwaite, Joycelyn A.
    Zhang, Caroline C.
    Refuerzo, Jerrie
    Pedroza, Claudia
    Lee, Kyung Hyun
    Chauhan, Suneet P.
    Sibai, Baha M.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S21 - S22
12345